Q1 2026 Holdings
Filed 2026-05-15 | 75 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $310.0M | 1,550,280 | 11.8% |
| iShares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $148.8M | 600,000 | 5.7% |
| Spdr Series Trust(XBI)Put | STATE STREET SPD | 78464A870 | $134.1M | 1,050,000 | 5.1% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $120.6M | 1,988,721 | 4.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $113.1M | 598,327 | 4.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $112.4M | 2,793,987 | 4.3% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $94.9M | 160,070 | 3.6% |
| AstraZeneca PLC(AZN) | ORD | G0593M107 | $89.9M | 456,031 | 3.4% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $86.6M | 150,000 | 3.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $81.4M | 2,113,551 | 3.1% |
| iShares TR(IBB)Put | ISHARES BIOTECH | 464287556 | $80.2M | 475,000 | 3.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $65.9M | 3,145,888 | 2.5% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $59.6M | 1,904,408 | 2.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $56.6M | 346,075 | 2.2% |
| Alcon AG(ALC) | ORD SHS | H01301128 | $55.0M | 729,972 | 2.1% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $49.3M | 954,309 | 1.9% |
| United Therapeutics Corp(UTHR)Put | COM | 91307C102 | $47.6M | 80,300 | 1.8% |
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $44.2M | 781,982 | 1.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $42.1M | 229,521 | 1.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $41.8M | 366,175 | 1.6% |
| BioAge Labs Inc(BIOA) | COM | 09077V100 | $40.1M | 2,293,788 | 1.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $39.1M | 450,096 | 1.5% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $39.1M | 1,696,752 | 1.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $37.7M | 1,131,786 | 1.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $37.2M | 1,701,904 | 1.4% |
| Nektar Therapeutics(NKTR) | COM | 640268306 | $36.7M | 509,546 | 1.4% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $36.0M | 212,747 | 1.4% |
| Immatics N.v(IMTX) | SHS | N44445109 | $35.7M | 3,630,454 | 1.4% |
| Celcuity Inc(CELC)Put | COM | 15102K100 | $34.2M | 300,000 | 1.3% |
| Axsome Therapeutics Inc.(AXSM)Put | COM | 05464T104 | $33.8M | 200,000 | 1.3% |
| BridgeBio Pharma Inc(BBIO) | COM | 10806X102 | $30.4M | 409,183 | 1.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $29.6M | 1,633,897 | 1.1% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $27.3M | 406,029 | 1.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $24.7M | 393,576 | 0.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $23.1M | 818,328 | 0.9% |
| Pfizer Inc(PFE)Call | COM | 717081103 | $22.5M | 800,000 | 0.9% |
| Praxis Precision Medicines Inc(PRAX) | COM | 74006W207 | $20.5M | 63,680 | 0.8% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $20.2M | 752,261 | 0.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $19.9M | 923,086 | 0.8% |
| Liquidia Corporation(LQDA)Put | COM | 53635D202 | $18.9M | 500,000 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $17.7M | 305,216 | 0.7% |
| Stryker Corporation(SYK) | COM | 863667101 | $14.6M | 44,480 | 0.6% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $13.8M | 248,253 | 0.5% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $13.2M | 477,995 | 0.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $12.2M | 386,498 | 0.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $10.9M | 2,056,161 | 0.4% |
| Exelixis Inc(EXEL)Put | COM | 30161Q104 | $10.8M | 251,500 | 0.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.6M | 679,578 | 0.3% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $8.3M | 395,081 | 0.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $7.8M | 204,015 | 0.3% |